Evaluation of non‐invasive prenatal RHD genotyping of the fetus

Abstract

Non-invasive testing of multiple exons provides a robust method of assessing fetal RHD status, and provides a safer alternative to amniocentesis for the management of RhD-negative pregnant women who are isoimmunised.